We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Dr. Jurate Lusienne, Clinical Trial Optimization at Jura Lasas Consulting. Lusienne helps small biotechs run early clinical trials faster, cheaper, and with more control—without relying on big CROs or fancy AI.
Drawing on experience across academia, CROs, and sponsor-side clinical ops in the US, Japan, UK, and Lithuania, she explains how founders can avoid expensive default decisions and design leaner, smarter trial strategies. We discuss how small teams can save 30–60% on Phase 1 and 2 trials, why sponsors remain responsible under GCP no matter who they outsource to, and the industry anti-pattern she sees most often: small biotechs choosing large CROs for a false sense of safety.
Check out the main topics of discussion for this episode of the Life Sciences Today podcast:
- Tell me about your personal journey – how did you end up doing what you’re doing?
- How do you create value for a biotech?
- The decisions we make in life science companies today— whether it’s in the clinical journey or before that in the application or scientific side— tend to be ingrained in the minds of the Founder and CEO: ‘this is what I have to do.’ This brings them to a point where years down the line, they’ve lost their optionality. Do you agree with that, or is that something that you think is just highly exaggerated on social media?
- How do you add value? What do you get people to do?
- Let’s say I’m a small biotech and I got a quote from a big CRO. How much could I expect to save in terms of time and money if I worked with you?
- What is your business model?
- Why would a biotech want to work with a big CRO instead of working with you?
- What are three things you want to do for your customers in the next twelve months?
- What is the biggest anti-pattern in your industry today?
- To what degree is it about learning for the biotech? When you outsource everything to a big CRO, it seems to me that the chances of a small biotech learning something new are kind of small. So maybe the secret sauce is that you’re actually helping these small biotechs learn a lot faster. Is that true?
Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.
Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:
Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.
If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.
Thanks so much for listening!
No comments:
Post a Comment